文献速递心脑血管急症

急诊医师主导的急性缺血性卒中快速治疗方案

Fast Protocol for Treating Acute Ischemic Stroke by Emergency Physicians.
PubMed 文献 · Ann Emerg Med · 2018-09-17
一句话结论在无卒中神经科医师时,急诊医师主导的方案使Door-to-needle中位时间从54分钟降至20分钟,不增加症状性颅内出血。

该研究为城市医院回顾性前后对照干预分析,2013年重组急性缺血性卒中治疗流程,由急诊医师主导。重组前(2009-2012年)107例和重组后(2013-2014年12个月)46例接受组织型纤溶酶原激活剂治疗。Door-to-needle中位时间从54分钟降至20分钟(差异估计32分钟,95%CI 26-38),发病至治疗中位时间从135分钟降至119分钟(差异估计23分钟,95%CI 6-39)。症状性颅内出血率分别为4.7%(5/107)和2.2%(1/46),差异2.5%(95%CI -8.7%至9.2%)。重组后约70%治疗患者功能独立(改良Rankin量表评分0-2)。

要点

  • 无卒中神经科医师时,急诊医师主导的卒中方案使Door-to-needle中位时间从54分钟降至20分钟(差异估计32分钟,95%CI 26-38)。
  • 发病至治疗中位时间从135分钟降至119分钟(差异估计23分钟,95%CI 6-39)。
  • 症状性颅内出血率重组前4.7%(5/107) vs 重组后2.2%(1/46),差异2.5%(95%CI -8.7%至9.2%),未增加。
  • 重组后约70%接受治疗的患者改良Rankin量表评分0-2(功能独立)。
  • 多变量回归分析中,仅分组(重组后 vs 重组前)对延迟的显著减少有贡献。

适用人群与场景

  • 城市医院中接受组织型纤溶酶原激活剂治疗的急性缺血性卒中患者,无卒中神经科医师可用。
  • 重组前组:2009-2012年治疗107例;重组后组:2013-2014年12个月内治疗46例。

处置流程与药物剂量

  • 2013年实施急性缺血性卒中治疗流程重组,采用急诊医师主导的方案。
  • 重组后Door-to-needle中位时间20分钟,重组前54分钟。
  • 重组后发病至治疗中位时间119分钟,重组前135分钟。

研究设计与关键结果

  • 研究类型:城市医院回顾性前后对照干预分析;重组前组107例(2009-2012年),重组后组46例(2013-2014年12个月)。
  • Door-to-needle中位时间:重组前54分钟 vs 重组后20分钟,差异估计32分钟(95%CI 26-38)。
  • 发病至治疗中位时间:重组前135分钟 vs 重组后119分钟,差异估计23分钟(95%CI 6-39)。
  • 症状性颅内出血率:重组前4.7%(5/107) vs 重组后2.2%(1/46),差异2.5%(95%CI -8.7%至9.2%)。
  • 重组后约70%治疗患者改良Rankin量表评分0-2。
  • 多变量线性回归中,仅分组(重组后 vs 重组前)对延迟减少有显著贡献。

证据类型、等级与局限

  • 证据类型:回顾性前后对照干预分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在无卒中神经科医师时,急诊医师主导的卒中方案可缩短Door-to-needle时间和发病至治疗时间,且未增加症状性颅内出血率(原文结论)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Thrombolysis with tissue plasminogen activator should occur promptly after ischemic stroke onset. Various strategies have attempted to improve door-to-needle time. Our objective is to evaluate a strategy that uses an emergency physician-based protocol when no stroke neurologist is available.

METHODS: This was a retrospective before-after intervention analysis in an urban hospital. Reorganization of the acute ischemic stroke treatment process was carried out in 2013. We evaluated time delay, symptomatic intracerebral hemorrhage, and clinical recovery of patients before and after the reorganization. We used multivariable linear regression to estimate the change in door-to-needle time before and after the reorganization.

RESULTS: A total of 107 patients with comparable data were treated with tissue plasminogen activator in 2009 to 2012 (group 1) and 46 patients were treated during 12 months in 2013 to 2014 (group 2). Median door-to-needle time was 54 minutes before the reorganization and 20 minutes after it (statistical estimate of difference 32 minutes; 95% confidence interval 26 to 38 minutes). After adjusting for several potential cofounders in multivariable regression analysis, the only factor contributing to a significant reduction in delay was group (after reorganization versus before). Median onset-to-treatment times were 135 and 119 minutes, respectively (statistical estimate of difference 23 minutes; 95% confidence interval 6 to 39 minutes). The rates of symptomatic intracerebral hemorrhage were 4.7% (5/107) and 2.2% (1/46), respectively (difference 2.5%; 95% confidence interval -8.7% to 9.2%). Approximately 70% of treated patients were functionally independent (modified Rankin Scale score 0 to 2) when treated after the reorganization.

CONCLUSION: Implementation of a stroke protocol with emergency physician-directed acute care decreased both door-to-needle time and onset-to-treatment time without increasing the rate of symptomatic intracerebral hemorrhage.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Heikkilä I, Kuusisto H, Holmberg M, et al. Fast Protocol for Treating Acute Ischemic Stroke by Emergency Physicians. Ann Emerg Med. 2018. PMID: 30236416. doi:10.1016/j.annemergmed.2018.07.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。